 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || CD7 CAR-T Cell / iCell Gene Therap
Trial completion date, Trial initiation date, Trial primary completion date, CAR T-Cell Therapy: CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma (clinicaltrials.gov) - Jul 6, 2022
P1, N=24, Recruiting, Sponsor: iCell Gene Therapeutics
Trial completion date: Oct 2023 --> Jun 2024 | Initiation date: Nov 2021 --> Jul 2022 | Trial primary completion date: Oct 2023 --> Jun 2024
- || CD7 CAR-T Cell / iCell Gene Therap
New P1 trial, CAR T-Cell Therapy: CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma (clinicaltrials.gov) - Jan 27, 2022
P1, N=24, Recruiting, Sponsor: iCell Gene Therapeutics
- || CD7 CAR-T Cell / iCell Gene Therap
New P1 trial, CAR T-Cell Therapy: Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances (clinicaltrials.gov) - Jun 22, 2021
P1, N=20, Recruiting, Sponsor: iCell Gene Therapeutics